Haematological symptoms

Diagnostics of haematological symptoms


 DO NOT

  • Do diagnostics unless it has important therapeutic implications without undue burden on the child.

General treatment of haematological symptoms

 

 




 DO

  • Provide information on causes, symptoms, treatment options and disease course of anaemia, increased bleeding tendency and thrombosis. 
  • In children in the palliative phase, always weigh the benefits of treating haematological conditions against the disadvantages and risks.
  • At risk of life-threatening bleeding:  
    • Discuss the possible impact of a life-threatening (pulmonary) haemorrhage with parent(s) and/or child. 
    • Discuss what to do in case of acute severe life-threatening bleeding. 
    • Provide dark towels in the home. 
    • Have an emergency kit at home for acute life-threatening bleeding with instructions on how to act and what medication to administer.
 

 Consider
  • In case of wish activities/fulfilment consider active intervention, which is temporarily effective, such as erythrocyte transfusion, platelet transfusion or Fresh Frozen Plasma (FFP) transfusion to reduce the risk of severe bleeding.

Treatment of anaemia

Erythropoietin

 DO NOT

  • Give erythropoietin in chemotherapy-associated anaemia.

Vitamins & iron


 DO NOT

  • Give vitamins and nutritional supplements in anaemia if life expectancy is short.

Erythrocyte transfusions

 

 DO

  • In children with long-term anaemia with bone marrow failure (e.g., MDS) in the palliative phase, adopt an individual transfusion policy based on perceived quality of life. 
  • In hematologic children with anaemia based on bone marrow failure, give erythrocyte transfusion on an individual basis at an Hb between 4.3-5.0 mmol/L or with symptoms of anaemia. 

Treatment of thrombocytopenia

Thrombocyte transfusions

 
 
DO

  • Adhere to the platelet limits from the national transfusion guideline in palliative procedures (such as placement of an epidural catheter). 



 Consider

  • In children with thrombocytopenia due to production disorder, consider adhering to the transfusion limits from your national transfusion guideline.
  • Before a particular physical activity with risk of bleeding, consider a platelet transfusion.

Treatment of bleeding    

 

 DO

  • Treat nasal bleeding with local adrenaline, xylometazoline, spongostan or possibly local coagulation by ENT physician.
  • Consult with a paediatric surgeon when local bleeding cannot be easily stopped.





 Consider

  • In bleeding due to thrombocytopathy, consider desmopressin (DDAVP).
  • For persistent or severe bleeding tendency due to coagulation factor deficiency, consider vitamin K, FFP and/or recombinant factor VII.  
  • In thrombocytopenia and mucosal bleeding (nasal, gum bleeding, menorrhagia) anti-fibrinolytic medication to reduce bleeding tendency. Do not give fibrinolytic drugs in haematuria.  
  • If bleeding occurs, consider platelet transfusion: see section on platelet transfusion.

Treatment of thrombosis        

 Consider

  • Consider giving a DOAC for symptomatic thrombosis.

Evaluation of hematologic symptoms

 
 
Consider

  • Evaluate the effect and side effects of the instituted treatment at the appropriate time, and adjust treatment as needed. Involve child and family in this process.